制药企业

• MYND Life Sciences Inc. Closes $2.4 Million Private Placement and Provides Update on Planned Listing 2021-01-07
• Ontario Brain Institute Increases Investment in Diamond Therapeutics to Accelerate Innovation in Mental Health 2021-01-07
• Paratek Pharmaceuticals Receives $60 Million Non-Recourse Loan from R-Bridge Healthcare Investment Advisory, Ltd., an affiliate of CBC Group 2021-01-05
• 博腾股份继承润生药业14.43%股权 介入干粉吸入剂领域 2021-01-03
• Amarillo Biosciences, Ind. Enters into a Securities Purchase Agreement to Foster New Growth 2020-12-31
• New Dermatology Company Resilia Pharmaceuticals Begins Operations 2020-12-28
• Aytu BioScience Announces Closing of $28.75 Million Bought Deal Offering and Full Exercise of Underwriter's Option to Purchase Additional Shares 2020-12-16
• 科创板受理|汇宇制药-多款注射剂获首家视同通过一致性评价 2020-12-02
• Baxter Announces Proposed $650 Million Senior Notes Offering 2020-10-29
• 先声药业(02096)今日上市，590倍超额认购、高瓴资本站台 2020-10-27

登录医药魔方官网 查看更多资讯